Philip J. Moos
Department of Pharmacology and Toxicology
Huntsman Cancer Institute
United States of America
Phillip Moos, PhD, is an assistant professor in the Department of Pharmacology and Toxicology at the University of Utah and a member of the Cell Response and Regulation Program at Huntsman Cancer Institute.Moos studies the reduction-oxidation relationship between inflammation and cancer. He is particularly interested in the role of selenoproteins in the origin of cancer. He also studies the role of thioredoxin reductase-1 in melanoma, and nanoparticles found in consumer products as potential initiators of inflammatory responses and cancer.Moos received a bachelor's degree from the University of Colorado, Boulder, and a PhD from Kansas State University.
Rock CM, Moos PJ (2008). Evaluation of the Antioxidant Activity of Selenoprotein P Against Lipid Hydroperoxides. Poster session presented at American Pharmacists Association (APhA) annual meeting, Philadelphia, PA..
Moos PJ, Chung K, Woessner D, Honeggar M, Veranth JM (2009). Zinc Oxide Nanoparticles: it’s the contact that kills. Poster session presented at 48th Annual Meeting of the Society of Toxicology, Baltimore, MD..
Moos PJ, J Griggs, S Leachman, P Cassidy, and JM Veranth (2010). Transcriptional and cytotoxic differences of nano-ZnO and nano-TiO2 in colon and skin-derived cell lines. Poster session presented at 49th Annual Meeting of the Society of Toxicology, Salt Lake City, UT..